These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7194181)

  • 1. Improved modification of yeast uricase with polyethylene glycol, accompanied with nonimmunoreactivity towards anti-uricase serum and high enzymic activity.
    Nishimura H; Matsushima A; Inada Y
    Enzyme; 1981; 26(1):49-53. PubMed ID: 7194181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of yeast uricase with polyethylene glycol: disappearance of binding ability towards anti-uricase serum.
    Nishimura H; Ashihara Y; Matsushima A; Inada Y
    Enzyme; 1979; 24(4):261-4. PubMed ID: 573687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on antigenicity of the polyethylene glycol (PEG)-modified uricase.
    Tsuji J; Hirose K; Kasahara E; Naitoh M; Yamamoto I
    Int J Immunopharmacol; 1985; 7(5):725-30. PubMed ID: 2412977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and biopharmaceutical properties of macromolecular conjugates of uricase with dextran and polyethylene glycol.
    Yasuda Y; Fujita T; Takakura Y; Hashida M; Sezaki H
    Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):2053-6. PubMed ID: 1702692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of tolerance in mice by uricase and monomethoxypolyethylene glycol-modified uricase.
    Savoca KV; Davis FF; Palczuk NC
    Int Arch Allergy Appl Immunol; 1984; 75(1):58-67. PubMed ID: 6746105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification with polysialic acid-PEG copolymer as a new method for improving the therapeutic efficacy of proteins.
    Wu J; Lu S; Zheng Z; Zhu L; Zhan X
    Prep Biochem Biotechnol; 2016 Nov; 46(8):788-797. PubMed ID: 26829568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of plasma urate levels in the cockerel with polyethylene glycol-uricase.
    Abuchowski A; Karp D; Davis FF
    J Pharmacol Exp Ther; 1981 Nov; 219(2):352-4. PubMed ID: 7288624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical modification of tryptophanase from E. coli with polyethylene glycol to reduce its immunoreactivity towards anti-tryptophanase antibodies.
    Yoshimoto T; Chao SG; Saito Y; Imamura I; Wada H; Inada Y
    Enzyme; 1986; 36(4):261-5. PubMed ID: 3552656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of amino groups in Candida utilis uricase with naphthoquinone disulfonic acid in relation to the enzymic activity.
    Yoshida K; Nishimura H; Takahashi K; Matsushima A; Inada Y
    FEBS Lett; 1981 Nov; 134(1):50-2. PubMed ID: 9222322
    [No Abstract]   [Full Text] [Related]  

  • 10. Properties of two urate oxidases modified by the covalent attachment of poly(ethylene glycol).
    Chen RH; Abuchowski A; Van Es T; Palczuk NC; Davis FF
    Biochim Biophys Acta; 1981 Aug; 660(2):293-8. PubMed ID: 7197160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studies.
    Bomalaski JS; Holtsberg FW; Ensor CM; Clark MA
    J Rheumatol; 2002 Sep; 29(9):1942-9. PubMed ID: 12233890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of modification of amino groups with poly(ethylene glycol) on a recombinant uricase from Bacillus fastidiosus.
    Zhang C; Yang X; Feng J; Yuan Y; Li X; Bu Y; Xie Y; Yuan H; Liao F
    Biosci Biotechnol Biochem; 2010; 74(6):1298-301. PubMed ID: 20530883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of batroxobin with activated polyethylene glycol: reduction of binding ability towards anti-batroxobin antibody and retention of defibrinogenation activity in circulation of preimmunized dogs.
    Nishimura H; Takahashi K; Sakurai K; Fujinuma K; Imamura Y; Ooba M; Inada Y
    Life Sci; 1983 Oct; 33(15):1467-73. PubMed ID: 6353117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypouricaemic effect after oral administration in chickens of polyethylene glycol-modified uricase entrapped in liposomes.
    Nishida Y; Kamatani N; Miyamoto T
    J Pharm Pharmacol; 1984 May; 36(5):354-5. PubMed ID: 6145782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of polyethylene glycol-modified uricase (PEG-uricase) to treat hyperuricemia in a patient with non-Hodgkin lymphoma.
    Chua CC; Greenberg ML; Viau AT; Nucci M; Brenckman WD; Hershfield MS
    Ann Intern Med; 1988 Jul; 109(2):114-7. PubMed ID: 3289428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and biopharmaceutical properties of PEGylated uricase.
    Freitas Dda S; Spencer PJ; Vassão RC; Abrahão-Neto J
    Int J Pharm; 2010 Mar; 387(1-2):215-22. PubMed ID: 19969053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective synthesis of 2,4-bis(O-methoxypolyethylene glycol)-6-chloro-s-triazine as a protein modifier.
    Ono K; Kai Y; Maeda H; Samizo F; Sakurai K; Nishimura H; Inada Y
    J Biomater Sci Polym Ed; 1991; 2(1):61-5. PubMed ID: 1863578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopharmaceutical properties of uricase conjugated to neutral and amphiphilic polymers.
    Caliceti P; Schiavon O; Veronese FM
    Bioconjug Chem; 1999; 10(4):638-46. PubMed ID: 10411462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological properties of uricase conjugated to neutral soluble polymers.
    Caliceti P; Schiavon O; Veronese FM
    Bioconjug Chem; 2001; 12(4):515-22. PubMed ID: 11459455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-yield expression, purification, characterization, and structure determination of tag-free Candida utilis uricase.
    Liu X; Wen M; Li J; Zhai F; Ruan J; Zhang L; Li S
    Appl Microbiol Biotechnol; 2011 Nov; 92(3):529-37. PubMed ID: 21573940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.